Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6823834 | Schizophrenia Research | 2015 | 4 Pages |
Abstract
Our preliminary results provide further support that acute doses of antipsychotic medications bind to the D3R and provide additional support for the further development of this receptor as a treatment target in schizophrenia.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Ragy R. Girgis, Xiaoyan Xu, Roberto B. Gil, Elizabeth Hackett, Najate Ojeil, Jeffrey A. Lieberman, Mark Slifstein, Anissa Abi-Dargham,